Antigen-Specific Signaling by a Soluble, Dimeric Peptide/Major Histocompatibility Complex Class II/Fc Chimera Leading to T Helper Cell Type 2 Differentiation

  title={Antigen-Specific Signaling by a Soluble, Dimeric Peptide/Major Histocompatibility Complex Class II/Fc Chimera Leading to T Helper Cell Type 2 Differentiation},
  author={Sofia Casares and Cong S. Zong and Dorel Lucian Radu and Alexander Miller and Constantin A. Bona and Teodor D. Brumeanu},
  journal={The Journal of Experimental Medicine},
  pages={543 - 554}
Interaction between a T cell receptor (TCR) and various ligands, i.e., anti-TCR antibodies, superantigens, peptides, or altered peptide ligands in the context of major histocompatibility complex (MHC) molecules can trigger different T helper cell (Th) effector functions. Herein, we studied the T cell response induced by a soluble, dimeric peptide/MHC class II chimera, namely hemagglutinin (HA)110-120/I-Edαβ/Fcγ2a (DEF). We have previously demonstrated that the soluble DEF molecule binds stably… 

Figures and Tables from this paper

Modulation of CD4 T cell function by soluble MHC II-peptide chimeras

Peptides antigens of 8 to 24 amino acid residues in length that are derived from processing of foreign proteins by antigen presenting cells (APC), and then presented to T cells in the context of

A Divalent Human Leukocyte Antigen-B7 Fusion-Protein Up-regulates CD25 and CD69 in Alloreactive CD8+ T Cells Bypassing CD28 Costimulation

The dichotomy in T-cell regulation by a divalent MHC fusion protein warrants the use of MHC multimers as custom-designed immune-regulatory molecules both in transplantation and autoimmune disease.

A Model for Antigen-Specific T-Cell Anergy: Displacement of CD4-p56lck Signalosome from the Lipid Rafts by a Soluble, Dimeric Peptide-MHC Class II Chimera1

The results argue for a model of anergy in which the defective partitioning of signaling molecules in lipid rafts is an early, negative signaling event in T cells, and Physiological ligands like DEF chimeras may provide new tools for silencing the autoimmune processes.

A Single-Chain Class II MHC-IgG3 Fusion Protein Inhibits Autoimmune Arthritis by Induction of Antigen-Specific Hyporesponsiveness1

In vivo administration of an I-Aq fusion protein, containing an immunodominant collagen II peptide, significantly delayed the onset and reduced the severity of collagen-induced arthritis in DBA/1 mice by induction of Ag-specific hyporesponsiveness.

Kinetics of T-cell Receptor Binding by Bivalent HLA-DR·Peptide Complexes That Activate Antigen-specific Human T-cells*

The results demonstrate that bivalent HLA-DR2·peptide complexes represent effective ligands for activation of the TCR, and support a role for TCR dimerization in early TCR signaling and kinetic proofreading.

Monovalent Engagement TCRs by MHC-Peptide Ligands but Not by Triggered by Multivalent Engagement of CD8 T Cells, Like CD4 T Cells, Are

The results show that MHC class I monomers bind to, but do not activate, CD8 T cells whether the cells are in solution or adhered to a surface, which is the same as previously observed for CD4 T cells.

Peptide-MHC Class II Dimers as Therapeutics to Modulate Antigen-Specific T Cell Responses in Autoimmune Diabetes1

Responsible peptide I-Ag7 dimers induce tolerance of BDC2.5 TCR T cells through a combination of the induction of clonal anergy and anti-inflammatory cytokines and Anti-IL-10R therapy reversed the tolerogenic effects of the dimer.

CD8 T Cells, Like CD4 T Cells, Are Triggered by Multivalent Engagement of TCRs by MHC-Peptide Ligands but Not by Monovalent Engagement1

The results show that MHC class I monomers bind to, but do not activate, CD8 T cells whether the cells are in solution or adhered to a surface, and the valency dependence of the response of CD8T cells to soluble MHC-peptide reagents is the same as previously observed for CD4 T cells.

Antigen-Specific Blockade of T Cells In Vivo Using Dimeric MHC Peptide1

  • Sean M. O’HerrinJill E. Slansky J. Bluestone
  • Biology, Medicine
    The Journal of Immunology
  • 2001
Soluble MHC dimers induced modulation of surface TCR expression and inhibited T cell cytolytic activity at nanomolar concentrations in vitro and in vivo, and Ag-specific inhibition of an alloreactive TCR-transgenic T cell population in vivo resulted in consequent outgrowth of anallogeneic tumor.

Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II–peptide chimera

A soluble bivalent MHC class II–peptide chimera is engineered on the immunoglobulin scaffold that binds stably and specifically to CD4 T cells recognizing the HA110-120 peptide and preserved both the binding capacity to hemagglutinin (HA)-specific T cells, and the drug toxicity.



Potent T Cell Activation with Dimeric Peptide–Major Histocompatibility Complex Class II Ligand: The Role of CD4 Coreceptor

Results indicate that dimerization of peptide-MHC class II using an IgG molecular scaffold significantly increases its binding avidity leading to an enhancement of its stimulatory capacity while maintaining the physiological properties of cognate peptide–MHC complex.

Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor

The soluble TCR is biologically active: it specifically inhibits antigen-dependent activation of the relevant T-cell clones and thus discriminates between proper and irrelevant peptides presented by major histocompatibility complex molecules.

Engineering and characterization of a murine MHC class II-immunoglobulin chimera expressing an immunodominant CD4 T viral epitope.

The chimeric molecule preserved the structural integrity of both MHC-peptide complex and Fc portion of IgG2a, and was able to bind specifically to the cognate T cell receptors (TCRs) and to the immunoglobulin FcgammaRII receptor (FcR), induce complement-mediated cell cytotoxicity, and trigger early production of IL-2 in cognates T cells.

Purified MHC class I and peptide complexes activate naive CD8+ T cells independently of the CD28/B7 and LFA-1/ICAM-1 costimulatory interactions.

It is demonstrated that immobilized MHC class I-peptide complexes can activate naive CD8+ T cells from TCR transgenic mice at low cell densities and the data suggest that under certain specific conditions of high intensity T cell signaling, early activation and late cell proliferation can occur independently of APC-derived costimulatory signals.

Single-chain MHC class II molecules induce T cell activation and apoptosis.

Evidence is presented here that components of this heterotrimeric complex can be genetically linked into a single polypeptide chain and open up the possibility of producing large amounts of stable sc class II/peptides fusion molecules for structural characterization and immunotherapeutic applications.

Production of soluble MHC class II proteins with covalently bound single peptides

This work has tackled the problem for MHC class II proteins by genetically attaching the peptide by a flexible peptide linker to the amino terminus of the class II β-chain and reports that a secreted, soluble form of this covalent peptide-MHC complex can be expressed in insect cells.

Naive alloreactive CD8 T cells are activated by purified major histocompatibility complex class I and antigenic peptide

It is demonstrated that particular TCR antigen pairs may overcome the need for specialized antigen‐presenting cells and have implications for mechanisms of autoimmunity and tolerance induction.

Quantitative Contribution of CD4 and CD8 to T Cell Antigen Receptor Serial Triggering

It is reported that during T cell–antigen-presenting cell interaction, triggered TCRs and coreceptors are downregulated and degraded with identical kinetics.